Role and limitation of FMPSPGR dynamic contrast scanning in the follow-up of patients with hepatocellular carcinoma treated by TACE

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 8, Issue 4

This Article

Citation of this article

Corresponding Author of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

All Articles published online

Item

Count

PDF

421

HTML

2353

Figures (1-1)

128

Tables (1-3)

117

Sum=3019

Aug 15, 2002 (publication date) through Apr 18, 2024

Times Cited of This Article

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Liver Cancer

World J Gastroenterol. Aug 15, 2002; 8(4): 658-662
Published online Aug 15, 2002. doi: 10.3748/wjg.v8.i4.658

Table 3 Comparison of MR findings on FMPSPGR sequence with pathology

FMPSPGR sequence	enhancement	pathological changes
enhanced early phase	enhanced area	viable tumors
	no enhanced area	necrosis
	enhanced area	viable tumors, inflammatory infiltration
enhanced late phase	no enhanced area	viable tumors, necrosis
	peripheral ring-like	viable tumors, inflammatory infiltration
	enhancement

Citation: Yan FH, Zhou KR, Cheng JM, Wang JH, Yan ZP, Da RR, Fan J, Ji Y. Role and limitation of FMPSPGR dynamic contrast scanning in the follow-up of patients with hepatocellular carcinoma treated by TACE. World J Gastroenterol 2002; 8(4): 658-662
URL: https://www.wjgnet.com/1007-9327/full/v8/i4/658.htm
DOI: https://dx.doi.org/10.3748/wjg.v8.i4.658